Advertisement

Hypercoagulability

  • Stanford Wessler
  • E. Thye Yin

Abstract

The concept that altered coagulation of the blood plays a role in thrombosis has a respectable lineage. Richard Wiseman was perhaps the first to apply the newly acquired knowledge of the circulation to the etiology of intravascular coagulation. In 1676, Wiseman described the properties of a thrombus and stated that intravascular coagulation was related, in part, to systemic alterations in the circulating blood (1). This concept, however, was destined to dominate neither the investigation of Wiseman’s day, nor of subsequent generations. Although Virchow almost 200 years after Wiseman mentioned hypercoagulability almost, as it were, in passing (2), data in support of the concept were not forthcoming.

Keywords

Clotting Factor Prothrombin Activator Blood Clotting Factor Vein Segment Bovine Plasma 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Wiseman, R.: Several Chirugical Treatises, 2nd ed., Norton and Macock, London, 1676, p. 64.Google Scholar
  2. 2.
    Virchow, R.: Gesammelte Abhandlugen zur Wissenschaftlichen Medicin. Frankfurt, Meidinger Sohn, 1856, p. 219..Google Scholar
  3. 3.
    Pechet, L. and Alexander, B.: Increased clotting factors in the gravid: a hypercoagulable state. New Eng. J. Med. 265:1093 (1961).PubMedCrossRefGoogle Scholar
  4. 4.
    Hougie, C., Rutherford, R.W., Banks, A.L. and Cobum, W.A.: Effect of a progestin-estrogen oral contraceptive on blood clotting factors. Metabolism 14:411 (1965).PubMedCrossRefGoogle Scholar
  5. 5.
    Egeberg, O.: Changes in the coagulation system following major surgical operations. Acta. Med. Scand. 171:679 (1962).PubMedCrossRefGoogle Scholar
  6. 6.
    Wright, H.P.: Changes in adhesiveness of blood platelets following parturition and surgical operations. J. Path. Bact. 54:461 (1942).CrossRefGoogle Scholar
  7. 7.
    Duckert, F. and Streuli, F.: Role of coagulation in thrombosis. In Pathogenesis and Treatment of Thromboembolic Diseases. International Symposium, Basle, Switzerland, 1966, Ed. F. Duckert, p. 185.Google Scholar
  8. 8.
    Ratnoff, O.D., Busse, R.J., Jr. and Sheon, R.P.: The demise of John Hageman. New Eng. J. Med. 279:760 (1968).CrossRefGoogle Scholar
  9. 9.
    McDonald, L. and Edgill, M.: Coagulability of the blood in ischaemic heart disease. Lancet ii:457 (1957).CrossRefGoogle Scholar
  10. 10.
    MacFarlane, R.G.: In General Pathology, 2nd ed. Edited by H. Florey, W.B. Saunders, London, 1959, p. 156.Google Scholar
  11. 11.
    Rokitansky, K.: A Manual of Pathological Anatomy (Translated by G.E. Day) London, Sydenham Society, Vol. 4, 1852, p. 261.Google Scholar
  12. 12.
    Astrup, T.: Neure Aspekte in der Blutgerinnung und der Fibrinolyse und ihren Beziehungen zur Koronarthroiribose und Koronarsklerose. Wien. Ztschr. f. inn. Med. 39:373 (1958).Google Scholar
  13. 13.
    Duguid, J.B.: Thrombosis as a factor in the pathogenesis of coronary atherosclerosis. J. Path. Bact. 58:207 (1946).PubMedCrossRefGoogle Scholar
  14. 14.
    Copley, A.L.: Thrombosis and Embolism. Schwabe, Basle, 1955, p. 458.Google Scholar
  15. 15.
    Roos, J.: Blood coagulation as a continuous process. Thronib. Diath. Haemorrh. 1:471 (1957).Google Scholar
  16. 16.
    Astrup, T.: Connective Tissue, Thrombosis and Atherosclerosis. Academic Press, New York, 1959, p. 223.Google Scholar
  17. 17.
    Adelson, E., Rheingold, J.J., Parker, O., Buenaventura, A. and Crosby, W.H.: Platelet and fibrinogen survival in normal and abnormal states of coagulation. Blood 17:267 (1961).PubMedGoogle Scholar
  18. 18.
    Hjort, P.P. and Hasselback, R.: A critical review of the evidence for a continuous hemostasis in vivo. Thronib. Diath. Haemorrh. 6:558 (1961).Google Scholar
  19. 19.
    Aster, R.H. and Jandl, J.H.: Platelet sequestration in man. I. Methods. J. Clin. Invest43: 843 (1964).Google Scholar
  20. 20.
    Mersky, C., Johnson, A.J., Kleiner, G.J. and Wohl, H.: The defibrination syndrome: clinical features and laboratory diagnosis. Brit. J. Haemat. 13:528 (1967).CrossRefGoogle Scholar
  21. 21.
    McKay, D.G.: Disseminated Intravascular Coagulation. An Intermediary Mechanism of Disease. Harper and Row, New York, 1965.Google Scholar
  22. 22.
    Hardaway, R.M., Watson, H.E. and Weiss, F.H.: Alterations in blood coagulation mechanisms after intra-aortic injection of thrombin. Arch. Surg.81: 983 (1960).PubMedCrossRefGoogle Scholar
  23. 23.
    Wessler, S. and Yin, E.T.: Experimental hypercoagulable state induced by Factor X: Comparison of non-activated and activated forms. J. Lab. Clin. Med. 72:256–260 (1968).PubMedGoogle Scholar
  24. 24.
    Duckert, F., Yin, E.T. and Straub, W.: Separation and purification of the blood clotting factors by means of chromatography and electrophoresis. Preparative methods. In Proc. VIII Colloquium. Protides of Biological Fluids. H. Peeters, ed. Elsevier Publishing Co., Amsterdam, 1961, p. 41.Google Scholar
  25. 25.
    Yin, E.T. and Wessler, S.: Bovine throiribin and activated Factor X: Separation and purification. J. Biol. Chem. 243:112–117 (1968).PubMedGoogle Scholar
  26. 26.
    Wessler, S., Reimer, S.M. and Sheps, M.C.: Biologic assay of a thrombosis-inducing activity in human serum. J. Appl. Physiol. 14:943 (1959).PubMedGoogle Scholar
  27. 27.
    Howell, W.H.: The nature and action of the thromboplastic (zymoplastic) substances of the tissues. Am. J. Physiol. 31:1 (1912).Google Scholar
  28. 28.
    MacFarlane, R.G., Trevan, J.W. and Atwood, A.M.P.: Participation of a fat soluble substance in coagulation of the blood. J. Physiol. 99:78 (1946).Google Scholar
  29. 29.
    Poole, J.C.F.: Fats and blood coagulation. Brit. Med. Bull. 14:253 (1958).PubMedGoogle Scholar
  30. 30.
    Connor, W.E., Hoak, J.C. and Warner, E.D.: Massive thrombosis produced by fatty acid infusion. J. Clin. Invest. 42:860 (1963).PubMedCrossRefGoogle Scholar
  31. 31.
    Milstone, J.H.: Thronibokinase as prime activator of oprthrombin: historical perspectives and present status. Fed. Proc. 23:742 (1964).PubMedGoogle Scholar
  32. 32.
    Barton, P.G., Jackson, C.M. and Hanahan, D.J.: Relationships between Factor V and activated Factor X in the generation of prothrombinase. Nature 214:923 (1967).PubMedCrossRefGoogle Scholar
  33. 33.
    Hemker, H.C. and Muller, A.D.: Kinetic aspects of the interaction of blood clotting enzymes. V. The reaction mechanism of the extrinsic clotting system as revealed by the kinetics of one-stage estimations of coagulation enzymes. Thromb. Diath. - Haemorrh. 19:368–382 (1968).PubMedGoogle Scholar
  34. 34.
    Yin, E.T. and Wessler, S.: Investigation of the apparent thrombogenicity of thrombin. Thromb. Diath. Haemorrh. (In press)Google Scholar
  35. 35.
    Ashford, T.P., Freiman, D.G. and Weinstein, M.C.: The role of the intrinsic fibrinolytic system in the prevention of stasis thrombosis in small veins: an electron microscope study. Am. J. Path. 52:1117 (1968).PubMedGoogle Scholar
  36. 36.
    Yin, E.T. and Wessler, S.: Evidence for a naturally occurring plasma inhibitor of activated Factor X: its isolation and partial purification. Thromb. Diath. Haemorrh. (In press)Google Scholar
  37. 37.
    Spaet, T.H.: Studies on the in vivo behavior of blood coagulation product I in rats. Thromb. Diath. Haemorrh. 8:276 (1962).PubMedGoogle Scholar
  38. 38.
    Merrill, E.W.: Rheology of human blood: in vitro observations and theoretical considerations. National Research Conference on Thrombosis. (In press).Google Scholar

Copyright information

© Plenum Press, New York 1969

Authors and Affiliations

  • Stanford Wessler
    • 1
    • 2
  • E. Thye Yin
    • 1
    • 2
  1. 1.Department of MedicineThe Jewish Hospital of St. LouisSt. LouisUSA
  2. 2.Department of MedicineThe Washington University School of MedicineSt. LouisUSA

Personalised recommendations